HIV and Heart Failure Work Featured

May 1, 2017

V-CREATE and VACS's work looking at individuals with HIV infection and their heart failure outcomes was recently featured in research news @ Vanderbilt. This is the first large study to reveal a higher risk of heart failure with reduced and preserved ejection fraction in HIV-infected individuals. The research news article highlights Dr. Freiberg's views regarding the implications of improved HIV treatment in the context of heart disease.

Watch Dr. Freiberg Speak at IAS 2015

September 3, 2015

Dr. Matthew Freiberg had the privilege of speaking at the International Aids Society (IAS) Conference in Vancouver in July of 2015. For those who were unable to attend the event, you can still learn about his participation in the conference right here.
 Dr. Freiberg was interviewed about how we should consider cardiovascular disease in the context of HIV.

Experts Invited to Discuss EPA's Clean Power Plan

July 15, 2015

On May 18th-19th, 2015, Vanderbilt University Law School and and Medical Center joined forces to present "The Clean Power Plan: Health, Energy Demand and Economic Effects". Held at the Law School, experts were invited to discuss U.S. Environmental Protection Agency’s proposed Clean Power Plan to significantly reduce carbon emissions from power plants.Policymakers, scholars, and practitioners were invited to speak to the group about the economic, energy demands, and health effects of the proposed act. Representing the health effects, Dr.

VACS Investigator to Speak at IAS Conference 2015

July 14, 2015

Dr. Freiberg was invited to speak at the International Aids Society Conference in Vancouver, Canada taking place from July 19-22, 2015. The IAS Conference focuses on HIV pathogensis, treatment, and prevention. Dr. Freiberg will speak on HIV and Cardiovascular Disease (CVD) outcomes in lower income countries as well as here in the U.S. Based on his work as an Investigator with the Veteran's Aging for the Cohort for the past decade.